Thrive Earlier Detection Corp lands $257m Series B

Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a healthcare company focused on incorporating earlier cancer detection into routine medical care, has raised $257 million in Series B financing.

ByIris Dorbian

29 July 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

Thrive Earlier Detection Corp lands $257m Series B

Brown Advisory

Casdin Capital

Janus Henderson Investors

Lux Capital Management

Perceptive Advisors

Rock Springs Capital

S32

Sands Capital

Related articles